Table 3.
Not Vaccinated n = 1103 (65.4%) |
Vaccinated with One Dose n = 92 (5.5%) |
Vaccinated with Two Doses or Monodose n = 321 (19%) |
Vaccinated with Three Doses n = 170 (10.1%) |
p-Value | |
---|---|---|---|---|---|
BSIs | 121 (10.9%) | 14 (15.2%) | 31 (9.6%) | 10 (5.9%) | 0.09 |
MDR colonization | 86 (7.8%) | 7 (7.6%) | 16 (4.9%) | 8 (4.7%) | 0.21 |
NVP | 240 (21.7%) | 20 (21.7%) | 64 (19.9%) | 37 (21.7%) | 0.92 |
UTI | 178 (16.1%) | 17 (18.5%) | 56 (17.4%) | 25 (14.7%) | 0.81 |
Clostridioides colitis | 8 (0.7%) | 1 (1.1%) | 2 (0.6%) | 3 (1.7%) | 0.53 |
CMV | 29 (2.6%) | 3 (3.3%) | 2 (0.6%) | 10 (5.9%) | 0.006 |
EBV | 134 (12.1%) | 6 (6.5%) | 14 (4.4%) | 10 (5.9%) | <<0.001 |
HIV | 3 (0.3%) | - | 1 (0.3%) | - | 0.86 |
Other respiratory viruses | 15 (1.3%) | 1 (1.1%) | 1 (0.3%) | 1 (0.6%) | 0.39 |
MDR, multi drug resistant; NVP, non-viral pneumonia; UTI, urinary tract infection; CMV, cytomegalovirus; EBV: Epstein–Barr virus; HIV: human immunodeficiency virus.